Earnings call transcripts

Earnings call transcripts with speakers and Q&A, usually within hours. Each one comes with a summary, the guidance management gave, and what analysts pressed on, free to read.

3,382 transcripts · 1,616 companiesHow to read a callBy API: the earnings call transcripts API.

Older calls

Page 11 of 282 · 3,382 calls

  • Northern Trust (NTRS) Q3 2026 earnings call

    Management framed the quarter as evidence that integrated growth and multi-year efficiency work are lifting returns, while emphasizing disciplined investment and execution.

    Oct 21, 2026Confident0.78
  • Chubb (CB) Q3 2026 earnings call

    Management framed Chubb as a diversified compounder, emphasizing underwriting discipline, rising investment income and growth opportunities despite softening commercial markets.

    Oct 21, 2026Positive0.65
  • CME Group (CME) Q3 2026 earnings call

    Management framed the quarter as evidence of broad-based client demand, emphasizing market integrity, capital efficiency and measured product expansion amid volatility.

    Oct 21, 2026Confident0.82
  • Elevance Health (ELV) Q3 2026 earnings call

    Management framed the quarter as evidence of improving operating momentum and a stronger starting point for 2027, while emphasizing diversified growth drivers.

    Oct 21, 2026Positive0.68
  • Healthcare Services Group (HCSG) Q3 2026 earnings call

    Management framed the quarter as evidence of improving organic momentum, while emphasizing acquisition-led expansion and maintaining established cost targets.

    Oct 21, 2026Confident0.72
  • Integra Lifesciences Holdings (IART) Q3 2026 earnings call

    Management framed the quarter as operational progress constrained by Cincinnati and uneven tissue reconstruction recovery, with cash generation and refinancing improving financial flexibility.

    Oct 21, 2026Mildly positive0.12
  • Wabtec (WAB) Q3 2026 earnings call

    Management framed the quarter as evidence of durable execution, stronger backlog coverage and accelerating operational gains, while highlighting freight-market unevenness and unquantified future opportunities.

    Oct 21, 2026Confident0.76
  • Weatherford International (WFRD) Q3 2026 earnings call

    Management framed Q3 as proof that execution and cash conversion can improve despite a weaker Middle East, while offshore awards and NCS widen the growth runway.

    Oct 21, 2026Positive0.65
  • Danaher (DHR) Q2 2026 earnings call

    Management framed the quarter as evidence of improving markets, while positioning its new agenda around commercial execution, connected selling, and focused innovation.

    Oct 21, 2026Confident0.72
  • Thermo Fisher Scientific (TMO) Q3 2026 earnings call

    Management framed the quarter as evidence of a broadening recovery, with stronger customer activity and execution supporting raised full-year expectations.

    Oct 21, 2026Confident0.83
  • Stride (LRN) Q1 2027 earnings call

    Management framed the quarter as an execution reset: demand remains, but technology friction hurt enrollment and leaders are redirecting resources toward family experience and student outcomes.

    Oct 20, 2026Cautious-0.35
  • Capital One (COF) Q3 2026 earnings call

    Management framed the quarter as evidence that Discover’s expected earnings power is now visible, while stressing continued investment and a gradual network migration.

    Oct 20, 2026Confident0.72

Companies covered

1,616 companies

152 more under A